Skip to main content

Table 2 Kaplan-Meier estimates of overall survival and cause-specific survival by histopathology

From: Prognostic value of histopathology and trends in cervical cancer: a SEER population study

Histology ICDO 4-digits n 10 year overall survival (95% confidence interval) 10 year cause-specific survival (95% confidence interval)
All   30989 57.8 (57.2–58.4) 74.2 (73.7–74.8)
Carcinoma not otherwise specified (NOS) 8010 1688 71.1 (68.9–73.4) 84.9 (83.1–86.7)
Squamous cell carcinoma microinvasive 8076 2910 90.6 (89.4–91.8) 98.7 (98.2–99.1)
Squamous cell carcinoma (SCC)   20755 52.3 (51.5–53.0) 69.7 (69.1–70.4)
   SCC nonkeratinizing, NOS 8072 2692 54.9 (52.9–57.0) 69.1 (67.1–71.0)
   SCC large cell, keratinizing 8071 2373 54.4 (52.2–56.6) 69.0 (66.9–71.1)
   SCC NOS 8070 15690 51.6 (50.7–52.4) 70.0 (69.2–70.8)
Adenosquamous carcinoma 8560 1120 50.7 (47.5–53.9) 66.6 (63.5–69.7)
Adenocarcinoma excluding mucinous   4015 60.9 (59.2–62.6) 77.9 (76.4–79.3)
   Endometrioid carcinoma 8380 198 68.9 (59.9–78.0) 87.9 (80.7–95.1)
   Adenocarcinoma NOS 8140 3302 61.5 (59.7–63.4) 77.3 (75.7–79.0)
   Papillary adenocarcinoma, NOS 8260 348 58.9 (53.4–64.4) 81.9 (77.3–86.4)
   Clear cell adenocarcinoma, NOS 8310 167 47.1 (38.6–55.5) 68.2 (59.9–76.4)
Mucinous adenocarcinoma   305 43.0 (36.5–49.5) 62.1 (55.4–68.8)
   Mucous adenocarcinoma 8480 181 43.6 (34.2–53.1) 64.1 (54.7–73.6)
   Mucin-secreting adenocarcinoma 8481 124 41.3 (32.1–50.5) 59.1 (49.2–68.9)
Small cell carcinoma NOS 8041 196 31.6 (24.5–38.8) 44.5 (36.7–52.4)